Allied Market Research published a report, titled, “Immunohematology Market by Product (Analyzers and Systems and Reagents), Application (Blood-related Diseases, HIV and Others), End User (Hospitals, Diagnostic Laboratories and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033″. According to the report, the global immunohematology market was valued at $1.9 billion in 2023, and is estimated to reach $3.0 billion by 2033, growing at a CAGR of 4.6% from 2024 to 2033.
๐๐ก๐๐ญ ๐๐ซ๐ ๐ญ๐ก๐ ๐๐ซ๐ข๐ฏ๐ข๐ง๐ ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐๐จ๐ซ ๐ญ๐ก๐ ๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ก๐๐ฆ๐๐ญ๐จ๐ฅ๐จ๐ ๐ฒ ๐๐๐ซ๐ค๐๐ญ?
Rising prevalence of blood disorders and chronic diseases, rise in geriatric population, increasing blood donations are the major factors that drive the growth of the immunohematology market growth. However, lack of awareness about the importance of immunohematology testing restricts the market growth. Moreover, technological advancements in immunohematology products offer remunerative opportunities for the expansion of the global immunohematology market.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/2126
๐๐จ๐ฉ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ ๐จ๐ ๐ญ๐ก๐ ๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ก๐๐ฆ๐๐ญ๐จ๐ฅ๐จ๐ ๐ฒ ๐๐๐ซ๐ค๐๐ญ
- Bio-Rad Laboratories, Inc
- Werfen
- Grifols, S.A.
- Danaher Corporation
- Siemens
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Merck KGaA
- Hoffmann-La Roche Ltd
- Cardinal Health
The report provides a detailed analysis of these key players in the global immunohematology market. These players have adopted different strategies such as product launch, product approval, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.
๐๐ฆ๐ฆ๐ฎ๐ง๐จ๐ก๐๐ฆ๐๐ญ๐จ๐ฅ๐จ๐ ๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐๐๐ง ๐๐ ๐๐จ๐ง๐ ๐๐๐ฌ๐๐ ๐จ๐ง ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐๐๐๐ญ๐จ๐ซ๐ฌ, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ :
By product, the immunohematology segment dominated the market share in 2023 owing to increase in prevalence of chronic diseases and the growing number of surgical procedures requiring blood transfusions. As healthcare systems worldwide advance, there is an increased focus on ensuring safe and efficient blood management practices. Immunohematology reagents play a crucial role in blood typing, antibody screening, and crossmatching, which are essential for preventing transfusion-related complications.
By application, blood related diseases segment the dominated the market share in 2023. This is attributed to rise in prevalence of conditions such as anemia, leukemia, lymphoma, and various hemoglobinopathies require precise diagnosis and careful management, which heavily depend on accurate blood typing, antibody screening, and crossmatching. Immunohematology tests are crucial for identifying specific blood group antigens and antibodies, ensuring that patients receive compatible and safe blood transfusions.
By end user, the hospitals segment dominated the market share in 2023. This is attributed to well-established laboratories equipped with advanced diagnostic tools and automated systems capable of handling large volumes of blood tests efficiently. These facilities employ skilled medical professionals who are trained in the latest immunohematology techniques, ensuring high accuracy and reliability in blood typing, antibody screening, and crossmatching procedures. The prevalence of chronic diseases such as cancer, cardiovascular disorders, and renal diseases, which often necessitate repeated blood transfusions, further increases the demand for immunohematology services within hospital settings.
North America holds a significant share of the global immunohematology market, primarily driven by the advanced healthcare infrastructure, high healthcare expenditure, and widespread adoption of cutting-edge technologies. The rise in prevalence of blood-related disorders such as anemia, leukemia, and lymphoma are high, necessitating robust hematology diagnostics and treatments further contributes towards the market growth.
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/2126
๐๐ฎ๐ซ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐๐ซ๐จ๐ฏ๐ข๐๐๐ฌ ๐๐จ๐ฎ ๐๐ง๐ฌ๐ฐ๐๐ซ ๐ญ๐จ ๐๐๐ฅ๐จ๐ฐ ๐๐๐ง๐ญ๐ข๐จ๐ง๐๐ ๐๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง:
- Which are the driving factors responsible for the growth of market?
- Which are the roadblock factors of this market?
- What are the new opportunities, by which market will grow in coming years?
- What are the trends of this market?
- Which are main factors responsible for new product launch?
- How big is the global & regional market in terms of revenue, sales and production?
- How far will the market grow in forecast period in terms of revenue, sales and production?
- Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
- How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
- Which region has more opportunities?
๐๐๐ ๐ข๐จ๐ง ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ:-
- North America
(U.S., Canada, Mexico)
- Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
- Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
- LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐๐ญ๐๐ข๐ฅ๐ฌ:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
๐๐๐จ๐ฎ๐ญ ๐๐ฌ
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
